BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2807622
Number of visits today
1001
Number of downloads
2059309
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Dai Z, Li R, Hou Y, Li Q, Zhao K, Li T, Li MJ, Wu X. Inducible CRISPRa screen identifies putative enhancers. J Genet Genomics 2021;48:917-27. [PMID: 34531148 DOI: 10.1016/j.jgg.2021.06.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Stankey CT, Lee JC. Translating non-coding genetic associations into a better understanding of immune-mediated disease. Dis Model Mech 2023;16:dmm049790. [PMID: 36897113 DOI: 10.1242/dmm.049790] [Reference Citation Analysis]
2 Lv X, Li Q, Liu H, Gong M, Zhao Y, Hu J, Wu F, Wu X. JUN activation modulates chromatin accessibility to drive TNFα ‐induced mesenchymal transition in glioblastoma. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17490] [Reference Citation Analysis]
3 Danziger O, Patel RS, Degrace EJ, Rosen MR, Rosenberg BR. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor. PLoS Pathog 2022;18:e1010464. [DOI: 10.1371/journal.ppat.1010464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
4 Danziger O, Patel RS, Degrace EJ, Rosen MR, Rosenberg BR. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor.. [DOI: 10.1101/2021.09.22.461286] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345